AETHOXYSKLEROL

Brand name authorized in: Austria Finland Lithuania Netherlands Poland United Kingdom

Active ingredients

The drug AETHOXYSKLEROL contains one active pharmaceutical ingredient (API):

1 Lauromacrogol 400
UNII 0AWH8BFG9A - POLIDOCANOL

Polidocanol has a concentration-dependent and volume-dependent damaging effect on the endothelium of blood vessels.

Read about Polidocanol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Polidocanol
C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BB Sclerosing agents for local injection
Discover more medicines within C05BB02

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 405647, 462069, 462093
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 115018, 115022, 115026, 115030, 115034
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1091315, 1091317, 1091318, 1091319
NL
Z-Index G-Standaard
Identifier(s): 14274655, 14274663, 14274671, 14274701
NL
Z-Index G-Standaard, PRK
Identifier(s): 2143, 3719, 3727, 3735
PL
Rejestru Produktów Leczniczych
Identifier(s): 100107315, 100107321, 100107338, 100169380, 100192723